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OBSERVATIONAL DATA INDI-cate that following an acutecoronary syndrome, thosewho adhere to a healthier
lifestyle have a lower risk of recurrent
events.1-3 Smoking cessation is associ-
atedwith a lower risk of death andmyo-
cardial infarction, high-quality diets1,4
and regular exercise are associatedwith
lower risk of death or recurrent cardio-
vascular disease events after a myocar-
dial infarction.1-3 Thus, avoidance of
smoking or its cessation, improving
diet quality, and increasing physical ac-
tivity level are recommended for sec-
ondary prevention of cardiovascular
disease.
Author Video Interview available at
www.jama.com.
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Importance Little is known about adoption of healthy lifestyle behaviors among in-
dividuals with a coronary heart disease (CHD) or stroke event in communities across a
range of countries worldwide.
Objective To examine the prevalence of avoidance or cessation of smoking, eating
a healthy diet, and undertaking regular physical activities by individuals with a CHD
or stroke event.
Design, Setting, and Participants Prospective Urban Rural Epidemiology (PURE)
was a large, prospective cohort study that used an epidemiological survey of 153 996
adults, aged 35 to 70 years, from 628 urban and rural communities in 3 high-income
countries (HIC), 7 upper-middle-income countries (UMIC), 3 lower-middle-income coun-
tries (LMIC), and 4 low-income countries (LIC), who were enrolled between January
2003 and December 2009.
Main OutcomeMeasures Smoking status (current, former, never), level of exer-
cise (low, 600 metabolic equivalent task [MET]-min/wk; moderate, 600-3000
MET-min/wk; high,3000MET-min/wk), and diet (classified by the Food Frequency
Questionnaire and defined using the Alternative Healthy Eating Index).
Results Among 7519 individuals with self-reported CHD (past event: median, 5.0
[interquartile range {IQR}, 2.0-10.0] years ago) or stroke (past event: median,
4.0 [IQR, 2.0-8.0] years ago), 18.5% (95% CI, 17.6%-19.4%) continued to smoke;
only 35.1% (95% CI, 29.6%-41.0%) undertook high levels of work- or leisure-
related physical activity, and 39.0% (95% CI, 30.0%-48.7%) had healthy diets;
14.3% (95% CI, 11.7%-17.3%) did not undertake any of the 3 healthy life-
style behaviors and 4.3% (95% CI, 3.1%-5.8%) had all 3. Overall, 52.5% (95% CI,
50.7%-54.3%) quit smoking (by income country classif ication: 74.9%
[95% CI, 71.1%-78.6%] in HIC; 56.5% [95% CI, 53.4%-58.6%] in UMIC; 42.6%
[95% CI, 39.6%-45.6%] in LMIC; and 38.1% [95% CI, 33.1%-43.2%] in LIC). Lev-
els of physical activity increased with increasing country income but this trend was
not statistically significant. The lowest prevalence of eating healthy diets was in LIC
(25.8%; 95% CI, 13.0%-44.8%) compared with LMIC (43.2%; 95% CI, 30.0%-
57.4%), UMIC (45.1%, 95% CI, 30.9%-60.1%), and HIC (43.4%, 95% CI, 21.0%-
68.7%).
Conclusion andRelevance Among a sample of patients with a CHD or stroke event
from countries with varying income levels, the prevalence of healthy lifestyle behav-
iors was low, with even lower levels in poorer countries.
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Previous studies examining the life-
style practices of individuals after vas-
cular events have included individu-
als within 2 years after the event; these
studies reported that only small pro-
portions of individuals followed rec-
ommended lifestyle practices.3-6 The
proportion of the estimated 100 mil-
lion individuals worldwide who have
vascular disease5 in the community, es-
pecially from lower-income coun-
tries, living in rural areas, and who
adopt healthy lifestyle behaviors is not
known. In this study, we examined the
prevalence of the 3 healthy lifestyle be-
haviors at enrollment (avoidance or ces-
sation of smoking, eating a healthy diet,
and undertaking regular physical ac-
tivities) in participants who report hav-
ing had a coronary heart disease (CHD)
or stroke event in the Prospective Ur-
banRural Epidemiology (PURE) study,
a large prospective cohort of individu-
als enrolled from urban and rural com-
munities in high-, middle-, and low-
income countries.7,8
METHODS
Themethodsandpopulationcharacter-
istics of the PURE study have been de-
scribed previously.7,8 Briefly, 153 996
adults (151 966 aged 35-70 years, 1444
aged 35 years, and 586 aged 70
years)were recruited from628 (348ur-
ban and 280 rural) communities in 17
low-,middle-,andhigh-incomecountries
of theworld,9,10 representingvarious lev-
els of development and encompassing a
large sociocultural diversity. Common
andstandardizedapproacheswereused
for theenumerationofhouseholds, iden-
tificationof individuals, recruitmentpro-
cedures, and data collection.
The method of approaching house-
holds differed between countries, but
was designed to avoid biases based on
levels of risk factors or prevalence of any
disease. Households were eligible if at
least 1 member of the household was
between the ages of 35 and 70 years and
the household members intended to
continue living at their current ad-
dress for another 4 years. All eligible in-
dividuals who provided written in-
formed consent were enrolled.
Training, Standardization,
and Data Collection
Toensure standardization andhighdata
quality, we used a comprehensive op-
erations manual, reinforced by peri-
odic training workshops, training
DVDs, and regular communications. All
datawere entered into a customized da-
tabase programmed with range and
consistency checks and transmitted
electronically to the project office at the
Population Health Research Institute
(Hamilton,Ontario,Canada)where fur-
ther quality-control measures were
implemented. Data collection oc-
curred at 4 levels: national, commu-
nity, household, and individual using
standardized and common question-
naires.9,10 We collected information
about smoking, physical activity level,
diet, and other risk factors using ques-
tionnaires from the INTERHEART1 and
INTERSTROKE2 studies aswell as other
studies.11-17
Definitions of Tobacco Smoking
Current smokers were individuals who
smoked at least 1 tobacco product
daily18 in the previous 12 months, in-
cluding those who had quit within the
past year. Former smokers had quit
more than 1 year earlier, either before
or after the clinical event. Never smok-
ers had never used tobacco products
regularly. Ever smokers included cur-
rent and former smokers. Smoking ces-
sation rates were the proportion of ever
smokers who had stopped smoking.
Former smokers who had quit during
the same year that their CHD or stroke
events had occurred were deemed to
have quit after the event.
Physical Activity
Information on physical activity at
work, at home, and during recre-
ational or sport and leisure-time
activities was obtained using the Inter-
national Physical Activity Question-
naire or regional questionnaires with
comparable variables.11 Questions
were asked about the specific activities
during the previous week that the
individual performed for at least 10
minutes, the total duration per day,
the number of days, and whether
the activity was heavy, moderate, or
low.
For each individual, the recorded ac-
tivities were converted to metabolic
equivalent task (MET)-minutes per
week.11 Individuals participating in ac-
tivities of less than 600 MET-min/wk
were classified as low, 600 to3000MET-
min/wk as moderate, and greater than
3000 MET-min/wk as having per-
formed a high level of physical activity.
Diet
Existing validated or newly developed
and validated Food Frequency Ques-
tionnaires were used.12-17 To enable
comparability of all data and calcula-
tion of nutrients, a master interna-
tional nutrient database was created,
primarily based on the US Depart-
ment of Agriculture’s food composi-
tion database and modified appropri-
ately with reference to local food
composition tables and supplemented
with the nutrient database that con-
tained recipes of locally eaten mixed
dishes. Food patterns were generated
using data from the Food Frequency
Questionnaires and following estab-
lished methods.12-17
The overall diet quality in this study
has been defined based on an adapta-
tion of the Alternative Healthy Eating
Index (AHEI), which was highly pre-
dictive of cardiovascular disease risk,
as described byMcCullough et al19 and
McCullough and Willett.20 We mea-
sured 6 of the 9 food items included in
the AHEI. Of these, 5 variables were
identical (vegetables, fruits, nuts and
soy protein, whole grain cereal fiber, ra-
tio of white to red meat, ratio of poly-
unsaturated to saturated fatty acid) and
1 itemwas comparable (deep fried foods
in place of transfats).21 We did not in-
clude alcohol andmultivitamin intake
in our scoring system. In 5 Muslim
countries (Bangladesh, Iran, Pakistan,
Malaysia, and United Arab Emirates),
the frequency of alcohol intakewas not
included in the Food Frequency
Questionnaires.
Alcohol was not included in the
analysis to allow inclusion of all indi-
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viduals in the study. Intake of multivi-
tamins was very low among low-
income and middle-income countries
andwas not included in the scoring sys-
tem; recent randomized studies havenot
indicated any protective effect of multi-
vitamins on cardiovascular disease. Our
method of scoring food quality and cut-
offs for scoring in themodifiedAHEIhas
been described previously.21 Overall
scores ranged from 6.2 to 70.0, with
higher scores indicating higher quality.
The population was stratified into 3
groups as eating unhealthy, less healthy,
and healthy diet, with cutoff points of
30.9 and 37.8.
Definition of Cardiovascular
Disease
A history of cardiovascular disease and
otherdiseaseswasobtainedfromeachpar-
ticipantusingstandardizedquestionnaires.
Coronaryheartdiseasewasbasedonself-
reportingofangina,myocardialinfarction,
coronary artery bypass graft surgery, or
percutaneouscoronaryangioplasty(each
category was not separately identified).
Stroke and diabetes were based on self-
report.Hypertensionwasidentifiedbyself-
report or a blood pressure level greater
than 140/90 mm Hg at enrollment. We
verifiedself-reportingof theseconditions
with medical or hospital records in a
sample of 455 reported events during
follow-up. The confirmation rates were
89% when adjudicated centrally.
Statistical Analysis
Theprevalenceofhealthylifestylebehav-
iors in the participants and their demo-
graphics were summarized using num-
berswithpercentagesaswellasmeansand
standard deviations or medians and in-
terquartile ranges(IQRs)asappropriate.
Meansandproportionswereadjustedfor
age,sex,andeconomicstatusofthecoun-
try as appropriate. For this purpose, the
generalized,linearmixed-effectmodelwas
usedtotakeintoaccounttheeffectofclus-
tering,withappropriatelinkfunctionand
random effect, in which logit link func-
tion was used for binary outcomes and
normal linkfunctionforcontinuousout-
comes.TheGLIMMIXprocedure inSAS
software version 9.2 (SAS Institute Inc)
was used to obtain adjusted rates for all
lifestyle behaviors for different strata in-
cludingcommunityasarandomeffect in
the model with additional adjustments.
Proportions andmeans were compared
using 2 and t tests, respectively, using
2-sided testing.APvalueof less than .05
was considered significant.
RESULTS
Participantenrollment in thestudy isde-
picted in FIGURE 1. Of the 153 996 en-
rolled participants, 16 073were from3
high-income countries, 43 518 from 7
upper-middle-incomecountries,59 742
from3 lower-middle-incomecountries,
and34663from4low-incomecountries;
7519 (4.9%)had aCHDor stroke event
(5650[3.7%]hadaCHDeventand2292
[1.5%]hada strokeevent; somepartici-
pants hadboth events). Themedian in-
terval fromeventtostudyenrollmentwas
5.0years (IQR,2.0-10.0years) forCHD
and 4.0 years (IQR, 2.0-8.0 years) for
stroke.Thebaselinecharacteristicsof the
participants includedinthestudyappear
in TABLE 1. Full details of the overall
study population and those with CHD
and stroke have been reported previ-
ously.8
Figure 1. Participant Enrollment
107 599 Households (382 341 individuals) agreed to
participate in the family census study
153 996 Included in primary analysis
123 114 Households (443 499 individuals)
in initial family census study
628 Communities selected
348 Urban
280 Rural
17 Countries included in study
4 Low-income countries (Bangladesh, India,
Pakistan, Zimbabwe)
3 Lower-middle-income countries (China,
Columbia, Iran)
7 Upper-middle-income countries (Argentina, Brazil,
Chile, Malaysia, Poland, South Africa, Turkey)
3 High-income countries (Canada, Sweden,
United Arab Emirates)
197 332 Individuals aged 35 to 70 y
1444 Individuals aged <35 y had complete
measurements and questionnaires
586 Individuals aged >70 y had complete
measurements and questionnaires
151 966 Had complete measurements
and questionnaires
153 662 Agreed to participate in adult study 
68 117 Men
85 461 Women
84 Sex data missing
185 009 Individuals aged <35 or >70 y
included in mortality follow-up only
15 515 Households (61 158 individuals)
refused to participate
43 670 Refused to participate in the
adult study but agreed to be
included in the mortality follow-up
24 669 Men
19 001 Women
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Smoking
Overall, 61.1% (95%CI, 60.0%-62.2%)
were never smokers, 20.4% (95% CI,
19.5%-21.3%)wereformersmokers,and
18.5%(95%CI,17.6%-19.4%)werecur-
rent smokers.Thereweredifferencesby
countryincomestatus,countryorregion,
and by education level (eTable at
http://www.jama.com).
Among the participantswhohad ever
smoked, 52.5% (95% CI, 50.7%-
54.3%)had stopped smoking; the preva-
lence of smoking cessation was highest
in the high-income countries (74.9%;
95%CI, 71.1%-78.6%) and lowest in the
low-income countries (38.1%; 95% CI,
33.1%-43.2%),with gradeddecreases by
decreasingcountry incomestatus (56.5%
[95%CI,53.4%-58.6%] inupper-middle-
income countries and 42.6% [95% CI,
39.6%-45.6%] in lower-middle-income
countries) (P.001 for trend).Thehigh-
est prevalences of smoking cessation
were found in countries in North
America and Europe (70.5%; 95% CI,
67.2%-73.8%) and South America
(67.2%;95%CI,63.4%-70.9%).The low-
est rate (14.4%; 95% CI, 8.1%-20.7%)
was inAfrica. Proportionally,moremen
stopped smoking (53.0%; 95% CI,
50.9%-55.1%) thanwomen(50.9%;95%
CI, 47.2%-54.6%) (P=.004) and more
urban (57.3%; 95% CI, 55.1%-59.6%)
than rural (44.4%; 95% CI, 41.5%-
47.4%) (P=.004) residents (eTable).
Whenexaminedby education andcoun-
try economic status, individuals from
high-income countries with the highest
level of education showed the highest
rate of smoking cessation (80.8%; 95%
CI, 72.5%-87.1%) comparedwith those
less educated (P=.004 for trend). These
patterns of increasing rates of smoking
cessationbyeducation levelwerealsoob-
served in the upper-middle-income
countries, lower-middle-income coun-
tries, and low-income countries
(TABLE 2).
Information on the date of quitting
smokingwas available from1296 of the
1526participants.Of these, 510 (39.4%)
stopped smokingafter theCHDor stroke
event. There was a graded increase in
quitting rates after an event, by decreas-
ing country income status, after adjust-
ing for age and sex (29.2% [95% CI,
23.4%-35.9%] in high-income coun-
tries; 34.1% [95% CI, 28.8%-39.9%] in
upper-middle-income countries; 46.7%
[95%CI,40.6%-53.0%] in lower-middle-
income countries, and 68.2% [95% CI,
58.3%-76.6%] in low-income coun-
tries) (P.001 for all trend compari-
sons).
Physical Activity Profiles
A littlemore thanone-third (35.1%; 95%
CI, 29.6%-41.0%) of individuals under-
took high levels of work- or leisure-
relatedphysical activities.Although there
weredifferences in theprevalenceofhigh
level of physical activity by country in-
come status, these did not reach statis-
tical significance. The prevalence was
25.5% (95% CI, 16.7%-36.6%) in low-
income countries, 41.5% (95% CI,
33.1%-50.4%) in lower-middle-income
Table 1. Baseline Characteristics of Participants With a Coronary Heart Disease (CHD) or
Stroke Event
No. (%) of Participants With an Eventa
CHD or Stroke
(n = 7519)
CHD
(n = 5650)
Stroke
(n = 2292)
Age, y
Mean (SD) 57.2 (9.0) 57.4 (8.8) 56.8 (9.4)
Median (IQR) 58.0 (51.0-64.0) 59.0 (52.0-64.0) 58.0 (51.0-64.0)
Sex
Female 4017 (53.4) 3036 (53.7) 1218 (53.1)
Male 3502 (46.6) 2614 (46.3) 1074 (46.9)
Country economic status
High 841 (11.2) 669 (11.8) 213 (9.3)
Upper-middle 1967 (26.2) 1396 (24.7) 691 (30.1)
Lower-middle 3669 (48.8) 2857 (50.6) 1042 (45.5)
Low 1042 (13.9) 728 (12.9) 346 (15.1)
Region or country
South Asia 970 (12.9) 683 (12.1) 316 (13.8)
China 3070 (40.8) 2407 (42.6) 872 (38.0)
Malaysia 440 (5.9) 289 (5.1) 193 (8.4)
Africa 283 (3.8) 207 (3.7) 91 (4.0)
North America/Europe 1216 (16.2) 951 (16.8) 323 (14.1)
Middle East 392 (5.2) 332 (5.9) 69 (3.0)
South America 1148 (15.3) 781 (13.8) 428 (18.7)
Type of community
Urban 4555 (60.6) 3447 (61.0) 1367 (59.6)
Rural 2964 (39.4) 2203 (39.0) 925 (40.4)
Educationb
None, primary school, or unknown 3640 (48.4) 2661 (47.2) 1185 (51.8)
Secondary or high school 2479 (33.0) 1889 (33.5) 731 (31.9)
Trade, college, or university 1382 (18.5) 1087 (19.3) 372 (16.3)
Smoking statusb
Never 4571 (61.1) 3479 (61.9) 1359 (59.6)
Former 1526 (20.4) 1158 (20.6) 447 (19.6)
Current 1382 (18.5) 982 (17.5) 475 (20.8)
Diabetes 1754 (23.3) 1367 (61.9) 549 (24.0)
Hypertension 5653 (75.2) 4275 (75.7) 1749 (76.3)
Body mass indexb,c
25 2717 (38.1) 2018 (37.3) 851 (39.9)
25-30 2771 (38.8) 2110 (39.0) 817 (38.3)
30 1650 (23.1) 1384 (23.7) 464 (21.8)
Time since diagnosis, median (IQR), y 5.0 (2.0-10.0) 5.0 (2.0-10.0) 4.0 (2.0-8.0)
Abbreviation: IQR, interquartile range.
aUnless otherwise indicated.
bThe percentages for this category do not add up to 100% due to missing data or incomplete measurements.
cCalculated as weight in kilograms divided by height in meters squared.
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countries, 29.9% (95% CI, 22.2%-
38.9%) in upper-middle-income coun-
tries, and 45.2% (95% CI, 29.8%-
61.5%) inhigh-incomecountries (P=.11
for trend). There were also differences
in prevalence of physical activity by edu-
cation level.However, thesepatterns var-
ied by country income level, and the dif-
ferences generally were not statistically
significant (Table 2).
Dietary Patterns
Using the modified AHEI score, 39.0%
(95% CI, 30.0%-48.7%) of individuals
with a history of CHD or stroke event
consumed a healthy diet. Low-income
countries had the lowest prevalencewho
hadhealthydiets (25.8%;95%CI,13.0%-
44.8%) compared with the prevalences
in high-income countries (43.4%; 95%
CI, 21.0%-68.7%), upper-middle-
income countries (45.1; 95%CI, 30.9%-
60.1%), and lower-middle-incomecoun-
tries (43.2%; 95% CI, 30.0%-57.4%)
(Table 2). Increasing levels of educa-
tion were associated with graded in-
creases in having healthy diets in high-
income countries (56.6% [95% CI,
28.7%-80.9%] among the highest edu-
cated and 31.1% [95% CI, 11.6%-
60.7%] among the lowest educated;
P.001 for trend). Similar trends were
seen for upper-middle-income, lower-
middle-income, and low-income coun-
tries (Table 2).
Combination of Healthy Lifestyle
Behaviors
Overall, 14.3% (95% CI, 11.7%-
17.3%) of individuals did not have any
of the 3 healthy lifestyle behaviors;
42.7% (95%CI, 39.3%-46.1%)had only
1 healthy behavior, 30.6% (95% CI,
27.4%-34.0%) had 2, and only 4.3%
(95%CI, 3.1%-5.8%) had all 3 healthy
lifestyle behaviors. Individuals inupper-
middle-income and low-income coun-
tries had higher prevalences of not hav-
ing any healthy lifestyle behaviors and
lower prevalences of having all 3
healthy lifestyle behaviors (FIGURE 2A).
Participants were more likely to have
2 or more healthy lifestyle behaviors if
they were from high-income coun-
tries (odds ratio [OR], 2.61; 95% CI,
2.11-3.22), upper-middle-incomecoun-
tries (OR, 1.42; 95%CI, 1.18-1.70), and
lower-middle-income countries (OR,
2.70; 95%CI, 2.33-3.13) vs those from
low-income countries. These patterns
are also reflected by lifestyle behav-
iors in the individual countries or re-
gions (Figure 2B).Urban residentswere
more likely to have 2 or more healthy
lifestyle behaviors than those living in
rural areas (OR, 1.22 [95% CI, 1.11-
1.34]; P .001).
Overall,moremendidnot followany
healthy lifestyle behaviors (26.4%; 95%
CI, 22.1%-31.1%) than women (7.2%;
95%CI,5.7%-9.0%(P.001;FIGURE3).
Conversely,morewomenhad3healthy
lifestylebehaviors (7.4%;95%CI,5.4%-
10.0%) thanmen (2.4%; 95%CI, 1.7%-
3.4%) (P.001); theORwas1.66 (95%
CI, 1.51-1.82) for women having 2 or
more healthy lifestyle behaviors com-
paredwithmen(P.001).Thesesexdif-
ferenceswere consistent by country in-
come status and by country or region.
DISCUSSION
This study shows that a large gap ex-
ists globally between actual and ideal
participation in the 3 key lifestyle be-
haviors of avoidance (or quitting) of
smoking, undertaking regular physi-
cal activity, and eating a healthy diet af-
ter a CHD or stroke event. Nearly one-
fifth of individuals continued to smoke,
only about one-third undertook high
levels of physical activity, and only two-
fifths were eating a healthy diet.
Substantial proportions of individu-
als did not have any of these 3 healthy
lifestyle behaviors and less than 1 in 20
Table 2. Prevalence of Smoking Cessation, Healthy Eating, and High Level of Physical Activity
Prevalence (95% CI)a
P
Values
for
TrendOverall
High-Income
Countries
Upper-Middle-
Income
Countries
Lower-Middle-
Income
Countries
Low-Income
Countries
Smoking cessation by education level
None or primary school 48.2 (41.5-55.0) 63.6 (49.7-75.5) 47.1 (35.8-58.7) 46.8 (36.6-57.2) 26.7 (19.9-34.7) .02
High or secondary school 54.2 (47.1-61.1) 69.5 (58.6-78.7) 55.8 (42.7-68.1) 51.6 (40.8-62.3) 36.4 (26.3-47.8) .02
Trade school, college, or university 57.7 (50.1-64.9) 80.8 (72.5-87.1) 56.5 (41.7-70.3) 47.5 (35.9-59.4) 47.7 (30.6-65.4) .001
All 53.4 (50.1-64.9) 70.8 (55.8-82.4) 54.6 (44.9-63.9) 47.6 (38.5-56.8) 39.3 (27.3-52.7) .001
Healthy eating by education level
None or primary school 32.2 (24.1-41.5) 31.1 (11.6-60.7) 38.1 (24.8-53.5) 37.0 (28.8-46.0) 19.4 (5.9-47.9) .61
High or secondary school 39.0 (29.9-49.0) 41.3 (17.6-69.8) 45.5 (30.2-61.8) 44.3 (35.3-53.7) 26.5 (8.6-58.1) .51
Trade school, college, or university 46.2 (36.2-56.5) 56.6 (28.7-80.9) 52.4 (35.4-68.8) 48.2 (38.4-58.1) 31.8 (10.3-65.4) .07
All 39.0 (30.0-48.7) 43.4 (21.0-68.7) 45.1 (30.9-60.1) 43.2 (30.0-57.4) 25.8 (13.0-44.8) .25
High level of physical activity by education level
None or primary school 34.8 (29.2-40.8) 36.0 (19.6-56.9) 29.9 (20.5-41.3) 39.5 (32.2-47.3) 29.5 (21.8-38.6) .64
High or secondary school 36.1 (30.2-42.3) 42.2 (24.6-62.0) 28.1 (18.6-40.0) 43.7 (35.9-51.8) 27.1 (19.6-36.1) .007
Trade school, college, or university 34.4 (28.5-40.8) 43.6 (26.1-62.9) 22.3 (13.9-33.8) 43.2 (34.9-51.9) 20.8 (13.1-31.4) .001
All 35.1 (29.6-41.0) 45.2 (29.8-61.5) 29.9 (22.2-38.9) 41.5 (33.1-50.4) 25.5 (16.7-36.8) .11
aAdjusted for age, sex, and education as appropriate based on mixed model.
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had all 3. More women than men had
2 or 3 healthy lifestyle behaviors. Our
study also shows important country
and sex differences. There were higher
rates of smoking cessation in high-
income countries than inupper-middle-
income, lower-middle-income, and
low-income countries. Lower preva-
lence of healthy diets was observed in
more individuals fromhigh-income and
low-income countries than in upper-
middle-income and lower-middle-
income countries.
Overall, individuals from upper-
middle-incomeandlow-incomecountries
hada lowerprevalenceof3of thehealthy
lifestylebehaviors than those fromhigh-
incomeandlower-middle-incomecoun-
tries. Higher levels of education tended
to be associated with higher prevalence
of healthy lifestyle behaviors in high-
incomeandlower-middle-incomecoun-
tries,butnotinupper-middle-incomeand
low-income countries, inwhich regular
physicalactivitywasundertakenless fre-
quently among the more educated.
These variations in lifestyle preva-
lence can provide insights into oppor-
tunities to enhance cardiovascular dis-
ease prevention through adopting
healthy lifestyle behaviors. For ex-
ample, high-income countries, and to
some extent upper-middle-income and
lower-middle-income countries, had
higher rates of smoking cessation than
low-incomecountries, especially among
themost educated. High-income coun-
tries had more comprehensive ap-
proaches to tobacco control (eg, edu-
cation on tobacco, smoking cessation
programs, and active taxation and leg-
islative measures), which likely ac-
count for the higher cessation rates. The
lower rates of smoking inwomen,most
pronounced in the lower-middle-
income and low-income countries, are
likely due to cultural factors and so-
cial stigma associated with women
smoking in these societies. However,
some reports suggest that as incomes
in these countries increase, smoking
among women could also increase.18,22
In addition, even though only about
one-third of those who quit smoking
did so after a CHD or stroke event, we
observed contrasting patterns in smok-
ing cessation by country income sta-
tus,with lower-income countries show-
ing a greater prevalence of smoking
Figure 2. Prevalence of Adoption of Combination of Healthy Lifestyle Behaviors by Country, Economic Status, and Region for Patients With a
Coronary Heart Disease or Stroke Event
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Figure 3. Prevalence of Adoption of Combination of Healthy Lifestyle Behaviors by Sex for
Patients With a Coronary Heart Disease or Stroke Event
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cessation after their events. Whether
this was a result of the cardiovascular
disease event or due to secular trends
in smoking cessation in these coun-
tries is not clear. Smoking cessation ef-
forts, which can have an effect in re-
ducing recurrent cardiovascular disease,
should specifically be targeted at those
with known cardiovascular disease, es-
pecially among men, and in poorer
countries. This should also be comple-
mented with continued efforts to pre-
vent individuals (especially women,
children, and young adults) from smok-
ing. Specific efforts to promote smok-
ing cessation are required in Africa
given the high rates of smoking and low
prevalence of smoking cessation.
Individuals fromhigh-income coun-
tries had the highest prevalence of high
levels of physical activity, followed by
lower-middle-income, upper-middle-
income, and low-income countries, in
that order, although these differences
were not statistically significant. A
greater proportion of individuals from
high-income countries had high lev-
els of physical activity as recreational
or leisure activity, whereas in the lower-
income countries, these levels of activ-
itywere predominantly related towork.
This suggests that the population’s eco-
nomic need to work in poorer coun-
tries (as opposed to participating in rec-
reational activities in richer countries)
may be an important consideration.
In our study, a healthy diet was fol-
lowed by less than half of individuals
in all the countries studied, except low-
income countries in which only one-
quarter had healthy diets. The obser-
vation that despite higher incomes,
individuals from high-income coun-
tries did not have a higher prevalence
of high-quality diets suggests that dif-
ferent factorsmay be operating in coun-
tries at different economic levels that
influence the adoption of healthy diets.
In wealthier countries, red meats and
fried foods are more commonly con-
sumed, whereas in the poorer coun-
tries, healthy foods such as fruits and
vegetables may not be affordable. The
challenges inherent in getting popula-
tions to improve the quality of their
diets are many and include cultural
influences, tastes, traditional cooking
methods, and availability and afford-
ability of healthy foods (such as fruits
and vegetables). Consequently, di-
etary recommendations from theWest-
ern or richer countries may not be ac-
ceptable ormaybeunaffordable in other
regions of the world. This should
lead to the development of locally sen-
sitive (to culture, affordability, avail-
ability, and taste) guidelines for healthy
diets.
Lifestylemodifications to reduce the
risk of recurrent cardiovascular dis-
ease events are as essential as using
proven secondary prevention medica-
tions such as -blockers, angiotensin-
converting enzyme inhibitors, statins,
and antiplatelet agents.8 Current ap-
proaches to modifying lifestyle behav-
iors, based on individual counseling, are
expensive and only modestly effec-
tive. In high-income countries, reha-
bilitation programs, mostly lasting for
a fewmonths, are offered to only a small
proportion of individuals with recent
vascular events who are referred to
these programs to initiate healthy life-
style practices.23 Moreover, such pro-
grams are not available inmost low- and
middle-income countries.Mendis et al24
reported that much higher propor-
tions of the 10 000 patients from 10
middle-income and low-income coun-
tries were aware of the cardiovascular
benefits of healthy lifestyle behaviors
than the much lower proportions of
those who actually were undertaking
these healthy lifestyle activities. This
suggests the existence of a large gap be-
tweenpatient knowledge of healthy life-
style behaviors and their adoption that
needs bridging.
Strengths and Limitations
Our study has several strengths. It is the
only studywe are aware of that has col-
lected information on lifestyle behav-
iors using standardizedmeasures from
a large number of urban and rural com-
munities in high-income, middle-
income, and low-income countries. The
identification of communities, partici-
pants, and the diagnoses of cardiovas-
cular disease using uniform ap-
proaches avoided the potential selection
biases related to collection of data only
for patients attending clinics or hospi-
tals. One limitation is that in individu-
als in whom the cardiovascular dis-
ease events occurredmore than 5 years
previously, obtaining the information
on current lifestyle is only a snapshot
of the activities that the individuals had
carried out recently. We were not able
to determine whether the adoption of
healthy diets and physical activity oc-
curred before or after the cardiovascu-
lar disease events. Nevertheless, this
study shows the large gaps between ac-
tual and ideal prevalence of healthy life-
style behaviors among those with pre-
vious CHD or stroke from high-,
middle-, and low-income countries and
in rural and urban areas.
CONCLUSIONS
Our data indicate that the prevalence
of following the 3 important healthy
lifestyle behaviors was low in individu-
als after their CHD or stroke event.
These patterns were observed world-
wide but more so in poorer countries.
This requires development of simple,
effective, and low-cost strategies for sec-
ondary prevention that is applicable
worldwide.
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